SBH Share Price Performance
€0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
SBH Community Narratives
There are no narratives available yet.
Recent SBH News & Updates
No updates
Sangui Biotech International, Inc. Key Details
Last Reported Earnings
Mar 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.00021
- Gross Margin
- 100.00%
- Net Profit Margin
- -36.89%
- Debt/Equity Ratio
- -72.3%
Sangui Biotech International, Inc. Competitors
About SBH
- Founded
- 1995
- Employees
- n/a
- CEO
- WebsiteView website
Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and wound dressing spray under the Granulox brand. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.
German Market Performance
- 7 Days: -0.2%
- 3 Months: -1.3%
- 1 Year: 19.8%
- Year to Date: 4.7%
Over the last 7 days, the market has remained flat, although notably the Communication Services sector gained 13% in that time. More promisingly, the market is up 22% over the past year. Looking forward, earnings are forecast to grow by 17% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading